Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
about
Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant TuberculosisMICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosisIn vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacinComparison of in vitro antimicrobial susceptibilities of Mycobacterium avium-M. intracellulare strains from patients with acquired immunodeficiency syndrome (AIDS), patients without AIDS, and animal sourcesMIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugsComparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosisAmikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige miceInhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophagesAnti-Mycobacterium avium activity of quinolones: in vitro activitiesComparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacinIn vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisSusceptibility testing of Mycobacterium avium complex isolatesActivities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige miceSpectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineMulticenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.Fluoroquinolones and tuberculosis.Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse modelRapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis.Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method.In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
P2860
Q21563671-36095FF7-4CC8-4BB0-A17C-A000558469A9Q28329425-C7CBB3FF-1533-45C8-8471-A4E30E3CF150Q28333965-81ED1849-42FB-4F17-A5C5-5CA2C0B66EF7Q28335823-746A965A-6119-4846-B2E1-6F1DF62841C8Q28339347-590567B6-231F-4E4B-BEB6-D5D7318C8AB8Q28340239-8280DEB3-C488-4240-82A7-2E88B7825D70Q28356424-69F2ACD3-7D04-4B00-A9F3-5AF7B2E135A7Q28369387-681A2EAE-5DC5-4BEE-A1AE-A476DA4B1955Q28378348-90F372C8-E4DD-40F6-99D4-EE4B18A76140Q28378625-91BAAD20-BDE6-4357-8168-C881449DF08BQ28379137-4861BEF4-DAD4-437E-B1DD-86B5958DB772Q28379189-16E49B28-129B-4930-BAB1-3E5C59BB2753Q28379216-88BCCD4C-3461-41FA-8032-D660CBC0F730Q28379290-D226349D-BF42-48CD-BA49-0F526C701466Q33962909-0316EE9A-4809-4A1D-9B7D-296A48C6611FQ34519143-174E4A09-FE39-4462-9F68-7811B7A64875Q35136593-ED87E9BA-BD8B-474D-A7F2-FC8C59E83A22Q35252460-C1164269-2D7B-491A-A05D-983FA6751888Q35363786-30EC6F0C-DE85-4BEA-B30D-7EFD03234547Q35822868-6C730E59-BDA1-4841-820C-51053A8A8299Q37133132-4E5EE914-7C88-4D5F-AAD1-62D3817DEA10Q38203355-94AB5ED3-EDA4-4FC5-A89B-3309EB66EE96Q39218265-3B097628-CAE1-4BD2-9C5D-1A4DDC7CFF59Q39218310-BE1010B3-C541-4E08-A210-F7418FEFFEADQ39780472-79AE1BFD-8CE0-4D99-864B-734148AFF989Q39782912-D41C63FD-74F6-4786-9214-6CE9F6E4AF8CQ42844479-A43362D4-8852-4E6F-9F63-A36213C7E611Q46802151-C34ABB47-7302-4BA5-B0F2-89A7682E4128
P2860
Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@en
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@nl
type
label
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@en
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@nl
prefLabel
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@en
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@nl
P1433
P1476
Bacteriostatic and bactericida ...... d Mycobacterium avium complex.
@en
P2093
Heifets LB
Lindholm-Levy PJ
P304
P356
10.1016/0041-3879(87)90067-5
P577
1987-12-01T00:00:00Z